Loading...
Indian Pharmaceutical Exporter · #2 for Pantoprazole · $67.8M export value · DGFT Verified
Aurobindo Pharma Ltd is the #2 Indian exporter of Pantoprazole with $67.8M in export value and 1,356 verified shipments. Aurobindo Pharma Ltd holds a 11.7% market share in Pantoprazole exports across 13 countries.
| $460.3K |
| 16 |
| 1.6% |
| CHINA | $359.2K | 8 | 1.3% |
| TANZANIA | $248.2K | 29 | 0.9% |
| NETHERLANDS | $86.1K | 5 | 0.3% |
| GERMANY | $83.7K | 3 | 0.3% |
| MEXICO | $42.7K | 2 | 0.1% |
Aurobindo Pharma Ltd exports Pantoprazole to 16 countries. The largest destination is MALTA accounting for 77.4% of Aurobindo Pharma Ltd's Pantoprazole shipments, followed by FRANCE (8.6%) and UNITED KINGDOM (5.4%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $15.3M | 1,016 |
| APL SWIFT SERVICES MALTA LIMITED | MALTA | $2.1M | 180 |
| APL SWIFT SERVICES (MALTA) LIMITED | MALTA | $1.8M | 115 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $1.5M | 83 |
| ARROW GENERIQUES, | FRANCE | $1.5M | 100 |
| XXROBXXDO XXARMXXUSAXXNC | UNITED STATES OF AMERICA | $1.1M | 23 |
| ARROW GENERIQUES | FRANCE | $807.9K | 38 |
| MILPHARM LIMITED, | UNITED KINGDOM | $734.6K | 23 |
| APL SWIFT SERVICES (MALTA) LTD. | MALTA | $474.3K | 51 |
| APL SWIFT SERVICES (MALTA) LIMITED, | MALTA | $443.7K | 101 |
Aurobindo Pharma Ltd supplies Pantoprazole to 43 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by APL SWIFT SERVICES MALTA LIMITED (MALTA) and APL SWIFT SERVICES (MALTA) LIMITED (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $231.0M worth of Pantoprazole through 11,610 shipments from 744 suppliers to 154 countries, serving 1,893 buyers globally. Aurobindo Pharma Ltd contributes $67.8M to this total, accounting for 11.7% of India's Pantoprazole exports. Aurobindo Pharma Ltd ships Pantoprazole to 16 countries through 43 buyers.
Aurobindo Pharma Ltd's average Pantoprazole shipment value is $50.0K per consignment, based on 1,356 shipments totaling $67.8M. The largest destination is MALTA (77.4% of Aurobindo Pharma Ltd's Pantoprazole exports).
Aurobindo Pharma Ltd ranks #2 among 744 Indian Pantoprazole exporters with a 11.7% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($67.8M), MYLAN LABORATORIES LIMITED ($33.0M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($31.0M). Aurobindo Pharma Ltd processed 1,356 shipments to 13 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PANTOPRAZOLE TABLETS 40MG(Pantoprazol Au | $3.2M | 120 |
| PANTOPRAZOLE TABLETS 40MG(Pantoprazol PU | $2.9M | 103 |
| PANTOPRAZOLE TABLETS 20MG(Pantoprazol Au | $1.8M | 72 |
| PANTOPRAZOLE TABLETS 20MG(Pantoprazole A | $886.4K | 21 |
| PANTOPRAZOLE TABLETS 20MG(Pantoprazol PU | $819.6K | 45 |
| PANTOPRAZOLE TABLETS 40MG(PANTOPRAZOL PUREN 40 MG MAGENSAFTRESISTENTE TABLETTEN)100'S | $646.8K | 29 |
| PANTOPRAZOLE TABLETS 40 MG 1000'S PACK | $533.6K | 11 |
| PANTOPRAZOLE TABLETS 40MG(PANTOPRAZOL AUROBINDO 40 MG, MAAGSAPRESISTENTE TABLETTEN)500'S | $494.7K | 28 |
| PANTOPRAZOLE TABLETS 40MGPantoprazol PUREN 40 mg magensaftresistente Tabletten100'S | $479.3K | 11 |
| PANTOPRAZOLE TABLETS 40MGPantoprazol PUREN 40 mg magensaftresistente Tabletten60'S | $355.0K | 14 |
Aurobindo Pharma Ltd exports 740 distinct Pantoprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PANTOPRAZOLE TABLETS 40MG(Pantoprazol Au with 120 shipments worth $3.2M.
What Aurobindo Pharma Ltd must comply with to export Pantoprazole to its top destination countries
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AUROBINDO PHARMA LTD ★ | $67.8M | 1,356 | 13 | $50.0K |
| 1 | MYLAN LABORATORIES LIMITED | $33.0M | 661 | 10 | $50.0K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $31.0M | 776 | 19 | $40.0K |
Aurobindo Pharma Ltd ranks #2 among 744 Indian Pantoprazole exporters. Average shipment value of $50.0K compared to the market average of $310.5K. The closest competitors by value are MYLAN LABORATORIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,075 | 9.3% |
| SAHAR AIR | 926 | 8.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 821 | 7.1% |
| JNPT/ NHAVA SHEVA SEA | 652 | 5.6% |
| JNPT | 463 | 4.0% |
| VIZAG SEA | 455 | 3.9% |
| HYDERABAD AIR | 435 | 3.7% |
| DELHI AIR CARGO ACC (INDEL4) | 427 | 3.7% |
Visual overview of India's pantoprazole supplier profile for Aurobindo Pharma Ltd — top suppliers, destinations, pricing, and trade routes
Latest developments and market context
Detailed market intelligence for Pantoprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 154+ countries, 1,893+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Pantoprazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pantoprazole. For current shipment-level data, contact TransData Nexus.